Alpha-L-Fucosidase Has Diagnostic Value in Prostate Cancer With “Gray-Zone PSA” and Inhibits Cancer Progression via Regulating Glycosylation
BackgroundThis study aimed to explore the diagnostic value of alpha-l-fucosidase (AFU) in prostate cancer (PCa) patients with “gray-zone PSA” and to investigate the correlation between AFU expression and clinicopathological characteristics of PCa patients.MethodsThe level of AFU and other necessary...
Guardado en:
Autores principales: | Cong Zhang, Jikai Liu, Fan Chao, Shiyu Wang, Dawei Li, Dunsheng Han, Zhonghua Xu, Guoxiong Xu, Gang Chen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/55d1532a0f9041379a06f42beb7c748c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Analysis of the role of the interleukins in colon cancer
por: Wei,Xiyi, et al.
Publicado: (2020) -
Low Tumor-to-Stroma Ratio Reflects Protective Role of Stroma against Prostate Cancer Progression
por: Paulina Nastały, et al.
Publicado: (2021) -
Two Novel Ceramide-Like Molecules and miR-5100 Levels as Biomarkers Improve Prediction of Prostate Cancer in Gray-Zone PSA
por: Maurizia Mello-Grand, et al.
Publicado: (2021) -
MicroRNA-382 inhibits cell growth and migration in colorectal cancer by targeting SP1
por: Ren,Yupeng, et al.
Publicado: (2018) -
Post-Operative Radiotherapy in Prostate Cancer: Is It Time for a Belt and Braces Approach?
por: Nicolas Giraud, et al.
Publicado: (2021)